Astrazeneca Pharmaceuticals LP

A registered lobbying firm, and the clients it files for. Everything here comes from the quarterly disclosures it is required to make under the Lobbying Disclosure Act. Filed as ASTRAZENECA PHARMACEUTICALS LP.

Clients

named in its filings

Filings

2026

Fees reported

$4M

across every filing

Who it represents

Largest first, by what the filings report being paid.

Client	Ticker	Filings	Fees
Astrazeneca Pharmaceuticals LPAstraZeneca PLC	AZN	2	$4M

Every filing

Newest first, and within a year the largest.

Client	Lobbied on	Period	Fee
Astrazeneca Pharmaceuticals LP	Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code, Copyright/Patent/Trademark, Tariff (miscellaneous tariff bills), Trade (domestic/foreign)	1st Quarter (Jan 1 - Mar 31) 2026	$2.3M
Astrazeneca Pharmaceuticals LP	Health Issues, Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Tariff (miscellaneous tariff bills), Trade (domestic/foreign), Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code	2nd Quarter (Apr 1 - June 30) 2026	$1.7M

Source: quarterly LD-2 disclosures filed under the Lobbying Disclosure Act. A fee covers everything the firm did for that client in the period, so it cannot be attributed to any one issue on the list. A filing that states no figure contributes nothing rather than a zero. Clients with no ticker are kept: a trade association or a foreign ministry is as much a part of what the firm does as a listed company.

Related datasets

Corporate LobbyingWhat companies spend lobbying Congress, and on what.Government ContractsWhat federal agencies pay those same companies.Revolving DoorFormer staff now lobbying, and who they worked for.PatentsWhat those same companies are filing at the USPTO.